BioCancell Ltd (BICL) - Financial and Strategic SWOT Analysis Review

September 2017 | 33 pages | ID: B1A8911F0F0EN
GlobalData

Abstracts

BioCancell Ltd (BICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioCancell Ltd (BioCancell) is a biotechnology research and development company that focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancer-related diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The company's product pipeline candidates comprise BC-819 for the treatment of bladder cancer and BC-821, which being evaluated for the treatment of bladder cancer, ovarian cancer and pancreatic cancer. The company develops its products based on its proprietary, personalized cancer therapy approach H19, which plays a key role in the development, progress, drug resistance and metastasis of most human cancers. BioCancell is headquartered at Jerusalem, Israel.

BioCancell Ltd Key Recent Developments

Aug 14,2017: BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

BioCancell Ltd - Key Facts
BioCancell Ltd - Key Employees
BioCancell Ltd - Key Employee Biographies
BioCancell Ltd - Major Products and Services
BioCancell Ltd - History
BioCancell Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

BioCancell Ltd - Business Description
BioCancell Ltd - Corporate Strategy
BioCancell Ltd - SWOT Analysis
SWOT Analysis - Overview
BioCancell Ltd - Strengths
BioCancell Ltd - Weaknesses
BioCancell Ltd - Opportunities
BioCancell Ltd - Threats
BioCancell Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

BioCancell Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
BioCancell Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 14, 2017: BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

BioCancell Ltd, Key Facts
BioCancell Ltd, Key Employees
BioCancell Ltd, Key Employee Biographies
BioCancell Ltd, Major Products and Services
BioCancell Ltd, History
BioCancell Ltd, Other Locations
BioCancell Ltd, Key Competitors
BioCancell Ltd, Ratios based on current share price
BioCancell Ltd, Annual Ratios
BioCancell Ltd, Annual Ratios (Cont.1)
BioCancell Ltd, Interim Ratios
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
BioCancell Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

BioCancell Ltd, Performance Chart (2012 - 2016)
BioCancell Ltd, Ratio Charts
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Tikcro Technologies Ltd
Renopharm Ltd
Regentis Biomaterials Ltd
BioMAS Ltd
Abeome Corp